Cargando…

An amylin analog used as a challenge test for Alzheimer's disease

INTRODUCTION: Preclinical studies demonstrate the potential of amylin in the diagnosis of Alzheimer's disease (AD). We aimed to lay the foundation for repurposing the amylin analog and a diabetes drug, pramlintide, for AD in humans. METHODS: We administered a single subcutaneous injection of 60...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Haihao, Stern, Robert A., Tao, Qiushan, Bourlas, Alexandra, Essis, Maritza D., Chivukula, Meenakshi, Rosenzweig, James, Steenkamp, Devin, Xia, Weiming, Mercier, Gustavo A., Tripodis, Yorghos, Farlow, Martin, Kowall, Neil, Qiu, Wei Qiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Featured Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424531/ https://www.ncbi.nlm.nih.gov/pubmed/28503657 http://dx.doi.org/10.1016/j.trci.2016.12.002

Ejemplares similares

Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
por: Qiu, Wei Qiao, et al.
Publicado: (2014)

Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment
por: Qiu, Wei Qiao, et al.
Publicado: (2014)

Association of Plasma Amylin Concentration With Alzheimer Disease and Brain Structure in Older Adults
por: Zhu, Haihao, et al.
Publicado: (2019)

Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease
por: Soudy, Rania, et al.
Publicado: (2016)

Amylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity
por: Boyle, Christina Neuner, et al.
Publicado: (2017)

Association between Amylin and Amyloid-β Peptides in Plasma in the Context of Apolipoprotein E4 Allele
por: Qiu, Wei Qiao, et al.
Publicado: (2014)

Mini Mental State Examination and Logical Memory scores for entry into Alzheimer’s disease trials
por: Chapman, Kimberly R., et al.
Publicado: (2016)

Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology
por: Mez, Jesse, et al.
Publicado: (2021)

Midlife lipid and glucose levels are associated with Alzheimer's disease
por: Zhang, Xiaoling, et al.
Publicado: (2022)

Amylin in the Periphery
por: Wookey, Peter J., et al.
Publicado: (2003)

Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease
por: Zhu, H, et al.
Publicado: (2015)

Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease
por: Singh, Som, et al.
Publicado: (2022)

Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment
por: Corrigan, Rachel R., et al.
Publicado: (2022)

The Roles of Amylin in the Periphery
por: Wookey, P. J., et al.
Publicado: (2001)

Dynamic Factor Analysis for Multivariate Time Series: An Application to Cognitive Trajectories
por: Tripodis, Yorghos, et al.
Publicado: (2015)

Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity
por: Kiriyama, Yoshimitsu, et al.
Publicado: (2018)

Nuclear factor-kappa B: Glucocorticoid-induced leucine zipper interface analogs suppress pathology in an Alzheimer's disease model
por: Srinivasan, Mythily, et al.
Publicado: (2018)

Novel insights into amylin aggregation
por: Pillay, Karen, et al.
Publicado: (2014)

Monoconjugation of Human Amylin with Methylpolyethyleneglycol
por: Sisnande, Tháyna, et al.
Publicado: (2015)

Calcitonin/Amylin Receptors and Ramps
por: Sexton, Patrick M.
Publicado: (2001)

Amylin as a Neuroendocrine Hormone
por: Young, Andrew A.
Publicado: (2001)

Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease
por: Voss, Tiffini, et al.
Publicado: (2018)

The association of circulating amylin with β‐amyloid in familial Alzheimer's disease
por: Ly, Han, et al.
Publicado: (2021)

Integrative Review of the Interventions for Improving Patients’ Experiences Revealed in Quality Improvement Projects
por: Jun, Jin, et al.
Publicado: (2020)

Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study
por: Vandenberghe, Rik, et al.
Publicado: (2016)

#FakeMeat: How big a deal will animal meat analogs ultimately be?
por: Keefe, Lisa M
Publicado: (2018)

Angiotensin Converting Enzyme Inhibitors and the Reduced Risk of Alzheimer’s Disease in the Absence of Apolipoprotein E4 Allele
por: Qiu, Wei Qiao, et al.
Publicado: (2013)

Mediators of Amylin Action in Metabolic Control
por: Boyle, Christina N., et al.
Publicado: (2022)

Amylin as a Future Obesity Treatment
por: Dehestani, Babak, et al.
Publicado: (2021)

The costs of developing treatments for Alzheimer's disease: A retrospective exploration
por: Cummings, Jeffrey L., et al.
Publicado: (2021)

Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer’s Coordinating Center Uniform Data Set
por: Puzo, Christian, et al.
Publicado: (2019)

Amylin at the interface between metabolic and neurodegenerative disorders
por: Lutz, Thomas A., et al.
Publicado: (2015)

Charge-Based Inhibitors of Amylin Fibrillization and Toxicity
por: Patil, Sharadrao M., et al.
Publicado: (2015)

Amylin in the Periphery II: An Updated Mini-Review
por: Wookey, Peter J., et al.
Publicado: (2006)

Amylin Receptor: A Common Pathophysiological Target in Alzheimer’s Disease and Diabetes Mellitus
por: Fu, Wen, et al.
Publicado: (2013)

Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative
por: Marks, Brynn E., et al.
Publicado: (2023)

Development of Written Materials for Participants in an Alzheimer's Disease and Related Dementias Screening Trial
por: Head, Katharine J, et al.
Publicado: (2022)

Initiating Titratable Fixed-Ratio Combinations of Basal Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists: What You Need to Know
por: Skolnik, Neil, et al.
Publicado: (2018)

Correlation of leptin, neuropeptide Y and amylin in childhood obesity
por: Kim, Eun Young, et al.
Publicado: (2013)

Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation
por: López, Laura C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g1rmn11gom6pciace28u4kansh